Crohn Disease: all 1,923 studies

Page 8 of 20. Open to participants first (467), then studies with results posted, then the rest; newest registration first within each.

• SECURE, the Cimzia ® Crohn's Disease Post-Marketing RegistryCompletedNCT00844285Results posted
• Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED)CompletedNCT00818272Results posted
• Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)CompletedNCT00805766Phase 3Results posted
• Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's DiseaseTerminatedNCT00792740Phase 1/2Results posted
• Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel DiseaseCompletedNCT00791557Not applicableResults posted
• An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's DiseaseCompletedNCT00790933Phase 3Results posted
• Study of Vedolizumab (MLN0002) in Patients With Moderate to Severe Crohn's DiseaseCompletedNCT00783692Phase 3Results posted
• A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF TherapyCompletedNCT00771667Phase 2Results posted
• Effect of Increlex® on Children With Crohn DiseaseTerminatedNCT00764699Phase 2/3Results posted
• Remicade® Crohn's Disease Registry Across Canada (Study P02793)TerminatedNCT00755937Results posted
• Treatment With Infliximab in a Medical Setting (Study P05587)TerminatedNCT00752622Phase 4Results posted
• Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)CompletedNCT00727298Results posted
• Program Extension of Real Life Dosing of Remicade in Austria for Crohn's Disease (Study P04052)(COMPLETED)CompletedNCT00724958Results posted
• Assessment of the Social Cost of Crohn's Disease: Economic and Quality of Life Aspects (Study P04560)CompletedNCT00723840Results posted
• The Efficacy of Low Dose Naltrexone Therapy in Children With Crohn's DiseaseCompletedNCT00715117Phase 2Results posted
• Postmarketing Safety Surveillance European Registry of Crohn's Disease Patients Treated With Remicade or Standard Therapy (MK-2155-035)CompletedNCT00705614Results posted
• Infliximab for the Prevention of Recurrent Crohn's Disease After SurgeryCompletedNCT00688636Phase 4Results posted
• Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806CompletedNCT00686374Phase 3Results posted
• The Effects of Naltrexone on Active Crohn's DiseaseCompletedNCT00663117Phase 2Results posted
• Phase II Study of HMPL-004 in Subjects With Crohn's DiseaseCompletedNCT00655733Phase 2Results posted
• Vitamin D Levels in Children With IBDTerminatedNCT00621257Not applicableResults posted
• Long Term Safety of Vedolizumab (MLN0002) in Patients With Ulcerative Colitis and Crohn's DiseaseCompletedNCT00619489Phase 2Results posted
• A Study to Investigate the Safety and Efficacy of CP-690,550 in Patients With Moderate to Severe Crohn's DiseaseCompletedNCT00615199Phase 2Results posted
• Treatment of Crohn's Fistula Using a Porcine Intestine Submucosa GraftTerminatedNCT00610207Not applicableResults posted
• Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's DiseaseCompletedNCT00609973Phase 2Results posted
• Use of Oral Probiotics to Reduce Urinary Oxalate ExcretionCompletedNCT00587041Phase 1/2Results posted
• Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's DiseaseTerminatedNCT00584740Phase 2Results posted
• Efficacy and Safety Study of D9421-C 9 mg and 15 mg Versus Placebo in Japanese Patients With Active Crohn's DiseaseCompletedNCT00573469Phase 2Results posted
• A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's DiseaseCompletedNCT00552344Phase 3Results posted
• Study to Evaluate Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohn's DiseaseCompletedNCT00552058Phase 3Results posted
• A Long-Term Registry of Humira® (Adalimumab) in Subjects With Moderately to Severely Active Crohn's Disease (CD)CompletedNCT00524537Results posted
• Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal FistulasCompletedNCT00517296Phase 4Results posted
• Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's DiseaseTerminatedNCT00511329Phase 2/3Results posted
• High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in ChildrenTerminatedNCT00495521Phase 2Results posted
• Evaluation of Capsule Endoscopy in Patients With Suspected Crohn's DiseaseCompletedNCT00487396Not applicableResults posted
• Centocor Microarray Study of PatientsCompletedNCT00462072Phase 4Results posted
• A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's DiseaseCompletedNCT00445939Phase 2/3Results posted
• A Study of Adalimumab for the Maintenance of Clinical Remission in Japanese Subjects With Crohn's DiseaseCompletedNCT00445432Phase 2/3Results posted
• Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)CompletedNCT00427921Phase 3Results posted
• Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium AbsorptionCompletedNCT00427804Not applicableResults posted
• Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's DiseaseCompletedNCT00409682Phase 3Results posted
• Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's DiseaseCompletedNCT00409617Phase 3Results posted
• A Study of Abatacept in Patients With Active Crohn's DiseaseTerminatedNCT00406653Phase 3Results posted
• Bone Health in Pediatric Crohn's Disease: A Low Magnitude Mechanical Stimulus TrialCompletedNCT00364130Not applicableResults posted
• Examining the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Crohn's DiseaseCompletedNCT00356408Phase 3Results posted
• Corticosteroid Sparing Effect of Certolizumab in Crohn's DiseaseTerminatedNCT00349752Phase 3Results posted
• Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the ColonCompletedNCT00348283Phase 3Results posted
• Dietary Treatment of Crohn's DiseaseCompletedNCT00343642Phase 1/2Results posted
• Follow-up to Welcome Study C87042 [NCT00308581] Examining Certolizumab Pegol (CDP870) in Subjects With Crohn's DiseaseCompletedNCT00333788Phase 3Results posted
• Maintenance Study of Certolizumab Pegol (CZP) in Crohn's DiseaseCompletedNCT00329550Phase 2Results posted
• Maintenance Study Including Re-induction Therapy for Patients Who Did Not Show a Clinical Effect in Study C87037 (NCT00291668)CompletedNCT00329420Phase 2Results posted
• A Dose-finding Study of OPC-6535 in Patients With Active Crohn's DiseaseTerminatedNCT00317369Phase 2Results posted
• Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to InfliximabCompletedNCT00308581Phase 3Results posted
• Certolizumab Pegol for Treatment of Adult Greek Patients With Moderate to Severe Crohn's Disease Who Failed InfliximabTerminatedNCT00307931Phase 3Results posted
• Mucosal Healing Study in Crohn's Disease (CD)CompletedNCT00297648Phase 3Results posted
• Clinical Study of CDP870/Certolizumab Pegol in Patients With Active Crohn's DiseaseCompletedNCT00291668Phase 2Results posted
• Crohn's Disease Stem Cell TransplantationTerminatedNCT00271947Phase 2Results posted
• A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Participants With Crohn's DiseaseCompletedNCT00265122Phase 2Results posted
• Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's DiseaseCompletedNCT00195715Phase 3Results posted
• Safety of Celecoxib in Patients With Crohn's DiseaseTerminatedNCT00177866Phase 4Results posted
• Study for the Treatment of Crohn's Disease With AdacolumnCompletedNCT00162942Phase 3Results posted
• A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's DiseaseCompletedNCT00160706Phase 3Results posted
• A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]CompletedNCT00160524Phase 3Results posted
• Trial of Growth Hormone Therapy in Pediatric Crohn's DiseaseCompletedNCT00109473Phase 2Results posted
• Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONICCompletedNCT00094458Phase 3Results posted
• Remission in Subjects With Crohn's Disease, 1 Year PhaseCompletedNCT00055497Phase 3Results posted
• Incremental Value of Traditional Chinese Medicine Features in Two-Stage Pre-Endoscopic PredictionCompletedNCT07784114
• The Safety and Efficacy of Good Feeling Power® for IBD PatientsCompletedNCT07766733Not applicable
• Artificial Intelligence-Based Classification and Prognostic Prediction in Small Bowel Crohn's DiseaseCompletedNCT07757217
• Ustekinumab Real World Evidence StudyCompletedNCT07748338
• Efficacy and Safety of Low-Dose Upadacitinib Combined With Ustekinumab in the Treatment of Refractory Crohn's DiseaseCompletedNCT07697547
• Integrated Clinical-Occupational Management for Workers With Chronic Noncommunicable DiseasesActive, not recruitingNCT07694609
• Narrow Band Imaging Versus Artificial Intelligence for Colonic Surveillance in Inflammatory Bowel DiseaseCompletedNCT07694362Not applicable
• Can Vitamin D Replacement Correct Chronic Disease Anemia?CompletedNCT07673497Phase 4
• Effect of Isoflavone and Vitamin D Supplementation on Serum Vitamin D Levels, Body Composition, Inflammatory Markers, and Quality of Life in Patients With Inflammatory Bowel DiseaseCompletedNCT07656233Not applicable
• Treatment Adherence Among Patients With Inflammatory Bowel Disease Receiving Anti-TNF TherapyCompletedNCT07652840Not applicable
• Development of a Dynamic Prediction Model for Crohn's Disease-Related Intestinal Surgery Using Longitudinal Indices of Routine Blood Tests: A Single-Center Retrospective Cohort StudyCompletedNCT07644390
• Eating Disorders in Patients With IBDCompletedNCT07610694
• Assessment on the Deep Remission Rate and Its Influencing Factors of Individualized Ustekinumab Therapy in Patients With Crohn's DiseaseCompletedNCT07600255
• Upadacitinib in Isolated Small Bowel Versus Non-Small Bowel Crohn's DiseaseCompletedNCT07597577
• MRI-Based Screening in a Retrospective Cohort Reveals Adverse Prognosis of Asymptomatic Perianal Fistulas in Crohn's Disease: A Long-term Follow-Up StudyCompletedNCT07555808
• Feasibility Study of the SEGER Device in Laparoscopic Gastrointestinal SurgeryCompletedNCT07508592Not applicable
• A Study of PALI-2108 in Healthy Volunteers, Patients With Ulcerative Colitis, and Patients With Fibrostenosing Crohn's DiseaseActive, not recruitingNCT07428096Phase 1
• A Retrospective Study to Evaluate Treat-to-Target and Disease Modification in Adult Participants With Crohn's Disease and Ulcerative Colitis in Real World SettingCompletedNCT07421258
• Tissue Cytomegalovirus Viral Load and Associated Factors in Pediatric Patients Undergoing ColonoscopyCompletedNCT07419204
• Relationships of B-cell Activating Factor Gene Polymorphisms With Crohn's Disease.CompletedNCT07387172
• A Clinical Study on The Use of DL-endopeptidase-producing Probiotics as an Adjunctive Therapy for Inflammatory Bowel Disease.Active, not recruitingNCT07318753Not applicable
• Kinetics of Transmural Healing in Patients With Crohns Disease Treated With Risankizumab (SKYRIZI®)Active, not recruitingNCT07308067
• VedAryo® (Vedolizumab) Effectiveness and Safety EvaluationCompletedNCT07273760
• A Study on the Relationship of Interleukin-7 Receptor Gene Polymorphisms With the Risk of Crohn's Disease Onset and the Efficacy of InfliximabCompletedNCT07263477
• The Association Between TNFSF4 Polymorphism and CDCompletedNCT07263464
• A Study on Infections in Adults With Ulcerative Colitis/Crohn's DiseaseWithdrawnNCT07250815
• A Study to Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS)TerminatedNCT07222189Phase 2
• Real World Evidence Study With Restrictive Diet and Otral Nutritional Supplementation on Pediatric Patients With Active Chron DiseaseCompletedNCT07211789
• The Prospective Improved Vitamin D Study for Inflammatory Bowel Disease PatientsActive, not recruitingNCT07177157Phase 1
• Cranberry and Gut Health in Crohn's DiseaseCompletedNCT07170462Early Phase 1
• Implementation of Point Of Care UltraSound in the Assessment of Crohn's Disease -The POCUS StudyTerminatedNCT07157436
• Prospective, Multicenter Study on the Association Between Serum Ustekinumab Levels and Clinical, Biological and Endoscopic Remission in Patients With Crohn's Disease.CompletedNCT07100093
• ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy SubjectsCompletedNCT07089420
• An Analysis of the Relationship Between the Genetic Polymorphisms of Interleukin 12 Receptor Subunit Beta 1 and Crohn's Disease in Chinese PatientsCompletedNCT07057856

← Crohn Disease overview